β-Amyloid burden in healthy aging: regional distribution and cognitive consequences.
about
Evoked potentials and neuropsychological tests validate Positron Emission Topography (PET) brain metabolism in cognitively impaired patientsAre Anxiety Disorders Associated with Accelerated Aging? A Focus on NeuroprogressionPET Imaging of Epigenetic Influences on Alzheimer's DiseaseInsulin: an emerging treatment for Alzheimer's disease dementia?How does it STAC up? Revisiting the scaffolding theory of aging and cognitionThe relevance of beta-amyloid on markers of Alzheimer's disease in clinically normal individuals and factors that influence these associationsWhat can triumphs and tribulations from drug research in Alzheimer's disease tell us about the development of psychotropic drugs in general?Alzheimer's disease: Unique markers for diagnosis & new treatment modalitiesAtrophy rates in asymptomatic amyloidosis: implications for Alzheimer prevention trialsTaurine in drinking water recovers learning and memory in the adult APP/PS1 mouse model of Alzheimer's diseaseAssociation of Longitudinal Cognitive Decline With Amyloid Burden in Middle-aged and Older Adults: Evidence for a Dose-Response Relationship.Dietary cholesterol degrades rabbit long term memory for discrimination learning but facilitates acquisition of discrimination reversalEnvironmental enrichment strengthens corticocortical interactions and reduces amyloid-β oligomers in aged mice.The role of hippocampal iron concentration and hippocampal volume in age-related differences in memory.Practice effects and amyloid deposition: preliminary data on a method for enriching samples in clinical trials.The role of nutrition on cognition and brain health in ageing: a targeted approach.Ascorbic acid and the brain: rationale for the use against cognitive decline.Diagnostic utility of amyloid PET in cerebral amyloid angiopathy-related symptomatic intracerebral hemorrhage.Amyloid burden and neural function in people at risk for Alzheimer's Disease.Amyloid positron emission tomography in sporadic cerebral amyloid angiopathy: A systematic critical update18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation.Cerebral Blood Flow and Amyloid-β Interact to Affect Memory Performance in Cognitively Normal Older Adults.Is verbal episodic memory in elderly with amyloid deposits preserved through altered neuronal function?The effects of aging and Alzheimer's disease on cerebral cortical anatomy: specificity and differential relationships with cognitionAssociation of hypometabolism and amyloid levels in aging, normal subjectsWhite matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?Regional Fluid-Attenuated Inversion Recovery (FLAIR) at 7 Tesla correlates with amyloid beta in hippocampus and brainstem of cognitively normal elderly subjects.Should we disclose amyloid imaging results to cognitively normal individuals?Cognitive profile of amyloid burden and white matter hyperintensities in cognitively normal older adults.Molecular imaging of Alzheimer disease pathologyApolipoprotein E, gender, and Alzheimer's disease: an overlooked, but potent and promising interactionThe evolution of preclinical Alzheimer's disease: implications for prevention trials.Lobar microbleeds are associated with a decline in executive functioning in older adults.Contemplating Alzheimer's disease and the contribution of white matter hyperintensities.Alzheimer disease biomarkers, attentional control, and semantic memory retrieval: Synergistic and mediational effects of biomarkers on a sensitive cognitive measure in non-demented older adults.Brain structure and function as mediators of the effects of amyloid on memory.Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan.Age, Sex, and APOE ε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span.Brain Amyloid Deposition and Longitudinal Cognitive Decline in Nondemented Older Subjects: Results from a Multi-Ethnic Population.
P2860
Q21559700-47794426-F31F-4BED-A6BB-5785DC0C737CQ26765559-4531AB70-9259-465F-8027-C5D79493E2B6Q26776178-3730C6D8-2281-44CA-81FD-EDA1639B3E57Q26827376-9D6C1F2C-63F8-49F3-A833-3744BB6B5703Q26827532-9A99B1BE-DA4C-4640-BBED-C48644E5412EQ26830467-C5EFA01F-A524-421F-8BA0-964C0F066688Q28083481-8B184D6A-F4FF-4684-AD70-1C64CF900C68Q28085139-C88D796A-BD0C-4045-B225-97E3D25A1B7FQ28488143-02D52CBA-AA1C-45DA-9B93-3948BAFDDB18Q28649926-64076080-294F-40BB-B412-4C682B98A6C0Q30101023-F90DFF1B-BC33-427F-92DB-D50C8BE60A98Q30427264-02B73956-E1D7-4F4E-AC5F-B70CF1056416Q30443842-2E439AFB-3A90-40D6-A65F-48F81DBD59C2Q30540311-BB2A871F-66C0-4F82-A0A3-074CC59BFAA8Q30774130-B97572EF-E778-495B-ABEB-0590D9D10D2DQ31031167-9A5EB060-A6EE-4737-8584-23E76EB513F5Q33570528-27E60ACF-56BB-4F71-A35A-7F2F882CF842Q33581237-5067AA3C-928F-4B76-98E2-867A4A1852A1Q33599047-C7135C75-8C58-4517-8BC6-7513AD8449D1Q33700069-EA195E95-5462-4FF8-BD7C-631535206B9EQ33740879-85F7DF7E-C33D-4702-BDB7-8846E98B5C6EQ33741411-39A018C2-6964-49E4-B72F-C4D1D7E4D48CQ33775095-1228F34A-8398-4C04-8281-8767973155EDQ33872248-59A7FFBF-1F56-48EB-8865-7FB967EB7C8FQ33902744-34B661D4-94D3-42A1-99FA-E88459DC0541Q33927230-E4C0BBEC-F376-4703-B2E2-DF8FD2237873Q34013887-4CD2CE02-C5BF-4EFA-94F4-E8B42D481B28Q34154830-ABD22B4D-0AA7-4E2F-89CE-F44277EBA1D1Q34286140-106D9EBA-7B0E-44C2-9263-52ED8188ED33Q34311853-D7BAB927-54B7-4D2B-B8F6-D0CE739487C2Q34651135-0B7BE608-0A87-4117-A728-C17909A1DD53Q34808510-C3CA5C04-F1F5-49DC-8E60-019339B14904Q34849048-4BA2E743-7177-43F8-836D-6FB85079F789Q34993141-2FD43D3C-2702-47F3-BC8B-54052C20624DQ35031724-5F096BFB-778C-4882-B8B5-08374784993AQ35185590-F1565061-93CD-4281-888A-7DFB1DEB42DBQ35211063-44F5DEC9-0684-4FFD-90D6-52A795BD6ABFQ35229601-2EA913DA-89D2-4E67-A722-C3B5EF442AF8Q35598271-8C18E6E5-629C-4CCE-9E2C-C22378CFA608Q35722468-7252745B-9E97-43C0-9853-F10430D7D0F6
P2860
β-Amyloid burden in healthy aging: regional distribution and cognitive consequences.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
β-Amyloid burden in healthy aging: regional distribution and cognitive consequences.
@ast
β-Amyloid burden in healthy aging: regional distribution and cognitive consequences.
@en
type
label
β-Amyloid burden in healthy aging: regional distribution and cognitive consequences.
@ast
β-Amyloid burden in healthy aging: regional distribution and cognitive consequences.
@en
prefLabel
β-Amyloid burden in healthy aging: regional distribution and cognitive consequences.
@ast
β-Amyloid burden in healthy aging: regional distribution and cognitive consequences.
@en
P2093
P2860
P50
P1433
P1476
β-Amyloid burden in healthy aging: regional distribution and cognitive consequences
@en
P2093
P2860
P304
P356
10.1212/WNL.0B013E318245D295
P407
P577
2012-02-01T00:00:00Z